Your One True Source of Alternative Data
Eagle Alpha is the leading alternative data aggregation platform and advisor. Data VendorData BuyerSetting the Industry Standard for the Application of Alternative Data
We facilitate the overall functioning of the global alternative data market via our platform and workflow tools. Since its inception, more than 1,000 data buyers have interacted with our platform. We help them understand a vast and growing marketplace of over 2,000 alternative data products. Leading funds, private equity firms, consultants, corporates, and vendors trust Eagle Alpha as their key alternative data solution provider.
Alternative Data Events and Key Content
Alternative Data Infrastructure: The View from the Lakeshore
Our blog critiques the lofty aspirations of “data at your fingertips” versus the reality organizations face, highlighting the challenges with Data Warehouses and the complexity of data organization.
Data Sourcing: The Key to Any Alternative Data Initiative
Our blog analyzes a survey of 24 buyside funds, emphasizing the growing importance and cost of data sourcing in alternative data initiatives for asset managers.
Evaluating Alternative Data: Exabel and Eagle Alpha
Exabel and Eagle Alpha’s partnership addresses operational and technical challenges in alternative data, combining expertise and analysis for efficient data evaluation at scale.
Most Squeezable Stocks in the United States
This guest blog details the post-June 16 rally (S&P 500, Nasdaq, Russell 3000 up) and a surge in squeezable stocks, highlighting Consumer Discretionary and Healthcare as top sectors.
Alternative Data for Healthcare
This white paper explores the impact of alternative data sources on the healthcare industry, emphasizing their role in enhancing investment decisions in healthcare startups, therapies, and market trends. It delves into patient-generated data, wearables, mobile health apps, social media discussions, and electronic health records (EHRs) as key non-traditional data sources. The report segments healthcare data into four primary categories: R&D and clinical trials, claims data, medical devices data, and other relevant datasets, underscoring the transformative role of AI in healthcare processes. The paper includes sections on investment trends in pharma and biomed, data availability and its applications, the evolution of the pharma industry through AI, real-world case studies demonstrating successful data utilization, and compliance considerations for investors. This summary offers a glimpse into the comprehensive insights provided in the full report by Eagle Alpha, which further includes additional case studies and details on alternative data providers not covered here. For more detailed information and access to a broad catalog of data products, the report encourages contacting Eagle Alpha directly.
Where We Are in Generative AI Compliance
Generative AI is transforming investment management and data analysis, making compliance an essential area of focus for both investors and regulators.
Profiting From Data with Lowenstein Sandler – Q3 App Annie Wrap
Once a quarter, Eagle Alpha’s director of data strategy and analytics, Ronan Crosson, is joined by Peter Greene and Ben Kozinn from New York law firm, Lowenstein Sandler. These conversations are part of Eagle Alpha’s client-only monthly legal workshops. In this episode, Peter and Ben discuss this quarter’s most pertinent topic in the alternative data industry surrounding mobile app data provider, App Annie, and the SEC’s decision to charge them with securities fraud. The group addresses the confusion surrounding the use of insider trading law in this securities fraud case, its impact on the decision on the wider market, and provides expert advice for app data buyers following the SEC’s decision. Please enjoy this dialogue between Peter Greene, Ben Kozinn, and your host, Ronan Crosson.
Get a Demo
Request a demo of the vendor or buyer journey on our platform to learn how our services and solutions can help you unlock the potential of alternative data.